ClinicalTrials.gov
public full text
Public Domain
Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
VahatiCor's Coronary Sinus Reducer (A-FLUX) has been designed to improve angina or angina-like symptoms in patients with CMD. SERRA-I is an early feasibility study that evaluates the safety and clinical performance of the A-FLUX Reducer in this population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Coronary microvascular dysfunction: a narrative review.#358381
- Coronary Arterial Microcirculation and Metabolism#878699
- Chronic Total Occlusive Lesions CMR Study#863464
- PRECISE Phenotyping to Guide Therapies for Coronary Microvascular Dysfunction#1151358
- Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion#1306900
Record · ID 1185500
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive